Found 57 matching trials
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer PHASE2 The primary goal is to prospectively estimate the median PFS of African Ame...
Show More Location
Tulane University
Learn More & Join Trial
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC PHASE3 The purpose of this study is to determine if the addition of apalutamide to...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment NA Italian multicenter study, will enroll \~566 pts with oligometastatic hormo...
Show More Location
European Institute of Oncology
Learn More & Join Trial
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer PHASE3 This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Show More Location
The Mayo Clinic - Phoenix
Learn More & Join Trial
14C-ARN-509 Microtracer Label AME and Absolute BA Study PHASE1 This is study in healthy human volunteers to determine the absorption, meta...
Show More Location
PRA - Clinical Research Unit, University Medical Centre Groningen
Learn More & Join Trial
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS PHASE3 The purpose of this study is to determine if apalutamide plus gonadotropin ...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer PHASE1 The purpose of this study is to investigate potential drug-drug interaction...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer PHASE2 The proposed clinical trial will study the effects of 12 months of therapy ...
Show More Location
Multiple Locations
Learn More & Join Trial
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. PHASE2 The investigators have used national VHA data to demonstrate real-world eff...
Show More Location
VA Greater Los Angeles Healthcare System
Learn More & Join Trial
A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer PHASE2 The purpose of this study is to evaluate if the anti-tumor activity of JNJ-...
Show More Location
Multiple Locations
Learn More & Join Trial